Since 2007, our partner's stem cells have been used in the treatment of patients with visual impairment. Previously treated conditions include (but are not limited to):
- Optic Nerve Hypoplasia (ONH)
- Septo-Optic Dysplasia (SOD) with ONH
- Optic Nerve Atrophy (ONA)
- Leber’s Hereditary Optic Neuropathy (LHON)
- Retinitis Pigmentosa (RP)
- Retinopathy of Prematurity (ROP)
- Diabetic Retinopathy
Normal treatment protocol for visually impaired patients consists of umbilical cord blood-derived stem cells injected by IV and LP. Our partner hospital doctors are also performing retrobulbar injections for selected patients. This process involves injecting the stem cells into the retrobulbar space behind the eye socket. Our doctors can inform you after a medical review if this injection is an option for the treatment. There is the possibility of minimal/no improvement, and we encourage patients and caregivers to keep realistic expectations for the treatment.
General Treatment Protocol:
Below is the general treatment protocol for patients with visual impairment. Please keep in mind that this is only an example and the injection and cell types may change slightly depending on the patient’s condition. Some patients may receive a direct retrobulbar injection (decided by the doctors upon medical review).
- UCBSC packets injected by IV and LP
- UCBSC packets injected by IV, LP, and 1 retrobulbar injection
- Children with hormone problems may receive only IV